The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Theriva Biologics Inc’s current trading price is -88.84% away from its 52-week high, while its distance from the 52-week low is 67.54%. The stock’s price
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -83.72% since the start of this calendar year. Looking back over
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -87.91% since the start of this calendar year. Looking back over the last six months, we
All rights reserved © 2024, Powered By Smart TechOne
